Breathing easier: study tests two delivery methods for lung mucus drug
NCT ID NCT07293884
Summary
This study aims to see if inhaling a mucus-thinning drug (N-acetylcysteine) through a nebulizer is as good as or better than receiving it through an IV drip for adults hospitalized with a bronchiectasis flare-up. It will measure how well the drug helps clear thick mucus from the lungs and makes it easier to cough up. The goal is to improve breathing comfort during these episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHEICTASIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.